Skip to main content
NCBI home page
British Journal of Industrial Medicine logoLink to British Journal of Industrial Medicine
. 1970 Jan;27(1):67–71. doi: 10.1136/oem.27.1.67

Ampicillin in the treatment of brucellosis: A controlled therapeutic trial

D G McDevitt 1
PMCID: PMC1009044  PMID: 4907514

Abstract

McDevitt, D. G. (1970).Brit. J. industr. Med.,27, 67-71. Ampicillin in the treatment of brucellosis: A controlled therapeutic trial. A controlled therapeutic trial has been carried out with ampicillian in the treatment of brucellosis. Sixty-eight people, veterinary surgeons or their unqualified assistants, with serological evidence of brucella antibodies measured by the anti-human globulin (Coombs) test and the complement-fixation test, some of whom had symptoms consistent with a diagnosis of brucellosis, were treated in two random groups. One group was given ampicillin, 1 g. four times a day for 28 days; the other took a placebo in identical capsules for the same period. The response to treatment was gauged by subjective improvement in symptoms four weeks after its completion and by serological improvement after four months. Fifty-four people completed the trial.

There was no evidence that ampicillin was any more effective than the placebo in treatment, either symptomatically or serologically, but 25% of the people in both treatment groups reported subjective symptomatic improvement. It is suggested, therefore, that subjective improvement alone is an inadequate criterion for assessing response to treatment in culturally unproven brucellosis, and that, because of this, current conventional therapies may require critical revaluation. Similarly, a subjective therapeutic response cannot be relied upon for diagnostic confirmation in a patient in whom the diagnosis is uncertain.

Full text

PDF
67

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AGIUS E., MIFSUD J. The action of "Penbritin" on Brucella micro-organisms. Arch Inst Pasteur Tunis. 1962 Mar;39:97–101. [PubMed] [Google Scholar]
  2. BARTRAM H. G., BOTHWELL P. W., JEBB W. H., McDIARMID A., PRESTON A. E. Brucella abortus agglutinins in the sera of pregnant women and blood donors. Br J Prev Soc Med. 1963 Apr;17:95–100. doi: 10.1136/jech.17.2.95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BRADSTREET C. M., TAYLOR C. E. Technique of complementfixation test applicable to the diagnosis of virus diseases. Mon Bull Minist Health Public Health Lab Serv. 1962 May;21:96–104. [PubMed] [Google Scholar]
  4. Coghlan J. D., Weir D. M. Antibodies in human brucellosis. Br Med J. 1967 Apr 29;2(5547):269–271. doi: 10.1136/bmj.2.5547.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. FARID Z., BASSILY S., OMAR M. S. AMPICILLIN IN TREATMENT OF SALMONELLA TYPHI CARRIERS AND BRUCELLA MELITENSIS SEPTICAEMIA. Lancet. 1964 Oct 3;2(7362):763–763. doi: 10.1016/s0140-6736(64)92598-x. [DOI] [PubMed] [Google Scholar]
  6. FARID Z., MIALE A., Jr, OMAR M. S., VAN PEENEN P. F. Antibiotic treatment of acute brucellosis caused by Brucella melitensis. J Trop Med Hyg. 1961 Jul;64:157–163. [PubMed] [Google Scholar]
  7. Henderson R. J. Brucellosis in the dairy-farming community and allied workers of Worcestershire. Lancet. 1967 Aug 12;2(7511):353–357. doi: 10.1016/s0140-6736(67)90192-4. [DOI] [PubMed] [Google Scholar]
  8. KNUDSEN E. T., ROLINSON G. N., STEVENS S. Absorption and excretion of "Penbritin". Br Med J. 1961 Jul 22;2(5246):198–200. doi: 10.1136/bmj.2.5246.198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. MAGOFFIN R. L., SPINK W. W. The protection of intracellular brucella against streptomycin alone and in combination with other antibiotics. J Lab Clin Med. 1951 Jun;37(6):924–930. [PubMed] [Google Scholar]
  10. RICHARDSON M., HOLT J. N. Synergistic action of streptomycin with other antibiotics of intracellular Brucella abortus in vitro. J Bacteriol. 1962 Oct;84:638–646. doi: 10.1128/jb.84.4.638-646.1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. ROLINSON G. N., STEVENS S. Microbiological studies on a new broad-spectrum penicilin, "Penbritin". Br Med J. 1961 Jul 22;2(5246):191–196. doi: 10.1136/bmj.2.5246.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rizzo-Naudi J., Griscti-Soler N., Ganado W. Human brucellosis: an evaluation of antibiotics in the treatment of brucellosis. Postgrad Med J. 1967 Aug;43(502):520–526. doi: 10.1136/pgmj.43.502.520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. SHAFFER J. M., KUCERA C. J., SPINK W. W. The protection of intracellular brucella against therapeutic agents and the bactericidal action of serum. J Exp Med. 1953 Jan;97(1):77–90. doi: 10.1084/jem.97.1.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. SPINK W. W., BRADLEY G. M. Persistent parasitism in experimental brucellosis: attempts to eliminate brucellae with long-term tetracycline therapy. J Lab Clin Med. 1960 Apr;55:535–547. [PubMed] [Google Scholar]
  15. SPINK W. W. Some biologic and clinical problems related to intracellular parasitism in brucellosis. N Engl J Med. 1952 Oct 16;247(16):603–610. doi: 10.1056/NEJM195210162471605. [DOI] [PubMed] [Google Scholar]
  16. WILSON M. M., MERRIFIED E. V. O. The antiglobulin (Coombs) test in brucellosis. Lancet. 1951 Nov 17;2(6690):913–914. doi: 10.1016/s0140-6736(51)91875-2. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Industrial Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES